Concinnity Genetics (Seed)
Funding Details
Awarder
Inbox
Date Award
December 16, 2024
Vertical
Biotechnology
Funding URL
View Funding Page
Funding Amount
$3,000,000
Company Info
Founding Year
2023
Traction
Concinnity is preparing to spin out from the University of Edinburgh and initiate three new programmes in the cell and gene therapy market.
Founders
Jessica Birt, Dr. Matthew Dale
Market
Gene Therapy
Location
Edinburgh, UK
Coinvestors
Eos Advisory, Scottish Enterprise, Old College Capital, Maven Capital Partners
Company Description

Concinnity Genetics transform the safety of gene therapies by designing novel control mechanisms using AI platform.

Links
WebsiteCrunchbaseLinkedIn
Back to HomeBack to Biotechnology DealsView Funding Announcement